ENTRY       D08877                      Drug
NAME        Briobacept (USAN)
FORMULA     C2910H4542N814O878S24
EXACT_MASS  65706.9083
MOL_WEIGHT  65747.6875
SEQUENCE    DVRRGPRSLR GRDAPAPTPC NPAECFDPLV RHCVACGLLR TPRPKPAGAS SPAPRTALQP
            QESVGAGAGE AAVDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS
            HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA
            LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP
            ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPG
            (Disulfide bridge: 79-79', 82-82')
  TYPE      Peptide
EFFICACY    Immunosuppressant
COMMENT     Briobacept is a fusion protein consisting of human BR3 [HSA:115650] [KO:K05151] and human IgG1 Fc.
            Treatment of autoimmune disease
TARGET      TNFSF13B (BAFF, CD257) [HSA:10673] [KO:K05476]
  PATHWAY   hsa04060(10673)  Cytokine-cytokine receptor interaction
            hsa04064(10673)  NF-kappa B signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF13B (BAFF, CD257)
                 D08877  Briobacept (USAN)
DBLINKS     CAS: 869881-54-9
            PubChem: 96025560
///
